“…Screening uptake and LTBI treatment completion both appear to be suboptimal in real world conditions, despite the high risk of TB in HIV-infected individuals. 9,10 Interferon gamma release assays (IGRAs) could potentially be used to improve screening uptake, as IGRAs can be drawn with other routine bloodwork after HIV diagnosis, and they do not require a 48-72 hour return visit for reading. 6 However, IGRAs present their own challenges, including a lack of long-term followup data in HIV-infected populations, and high rates of conversion and reversion on serial testing.…”